Lawrence Panasci

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.

P Dombernowsky, I E Smith, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1998 · 640 citations

Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial

J.F.R. Robertson, Igor Bondarenko, Ekaterina Trishkina et al. · The Lancet · 2016 · 580 citations · Full text

Mg Versus, Breast Oncology, Oncology +8

Epstein‐barr virus related lymphoepithelioma‐like carcinoma of lung

Louis R. Bégin, Jan Eskandari, J. H. Joncas et al. · Journal of Surgical Oncology · 1987 · 241 citations

Epstein‐barr Virus, Lymphoid Neoplasia, Unusual Host +14

Systemic cancer therapy: achievements and challenges that lie ahead

Michael Palumbo, Petr Kavan, Wilson H. Miller et al. · Frontiers in Pharmacology · 2013 · 237 citations · Full text

Systemic Cancer Therapy, Medicine, Cancer Management +15

Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase

Carolyn Algire, Lilian Amrein, Mahvash Zakikhani et al. · Endocrine Related Cancer · 2010 · 232 citations